Posts tagged as: FullCircle Registry news back to homepage

FullCircle Registry Goes Profitable in Q1 at Georgetown Theater FullCircle Registry Goes Profitable in Q1 at Georgetown Theater(0)

After being hamstringed to a certain extent by nearly a year’s worth of road construction in front of its theater outside of Indianapolis, Indiana, FullCircle Registry, Inc. (OTCBB:FLCR) ratcheted-up business in the first quarter flagship movie complex.  The company recently said that the preliminary unaudited financials for the March 31, 2012 Quarter show that FullCircle Entertainment, Inc., its subsidiary which operates Read More

FullCircle Completes Digital Conversion at Theater, Ticket Sales Surge FullCircle Completes Digital Conversion at Theater, Ticket Sales Surge(0)

FullCircle Registry, Inc. (OTCBB:FLCR), a holding company that provides exit plans to successful businesses, had a bumpy road in front of it with its Georgetown 14 movie theater in Indianapolis, Indiana.  Literally.  Construction had been ongoing in front of the theater for approximately Read More

FullCircle Registry Signs LOI to Buy Another Movie Theater FullCircle Registry Signs LOI to Buy Another Movie Theater(0)

Looking to expand its footprint in a $12 billion U.S. industry, FullCircle Registry, Inc. (OTCBB:FLCR) has disclosed that its wholly-owned subsidiary, Full Circle Entertainment, Inc., yesterday entered into a non-binding Letter of Intent to acquire a 12-screen movie theatre complex in Elizabethtown, Kentucky.  If completed, the transaction will be the second theater acquisition for the company.

It is assumed that the Movie Palace pictured to the right is the source of the Letter of Intent.

FullCircle is in the process of completing its due diligence via a retained certified public accounting firm and independent appraiser to audit the theater’s finances and evaluate the property and assets.  According to the press, Movie Palace is in the process of converting from traditional film projection to digital projection with silver screens with the upgrades slated to be completed in late October of 2011.

FullCircle CEO Norman Frohreich commented,

While many exciting challenges are still ahead, I remain optimistic about FullCircle’s prospects for the future. We will continue to notify our shareholders as soon as possible once we have determined whether we will move forward with this acquisition.  In keeping with the business model we continue to look for profitable businesses in need of an exit strategy. We continue to be in discovery and negotiations to expand our company.

Although the future of the movie industry is questioned by some pundits, research by IBIS World explains, “Positive trends in consumer spending and a revival in demand for discretionary services like movie attendance will benefit the industry over the next five years. Movie theaters will invest in technologies like 3D to boost demand and increase ticket prices, supporting profitability. While competition from alternative services like video on demand remains, demand from moviegoers will remain steady.”

FullCircle Registry (FLCR) Stock Quote and News:

Disclaimer: Neither nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.